Concepedia

Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score

Marco Carbone, Alessandra Nardi, Steve Flack, Guido Carpino, Nikoletta Varvaropoulou, Caius Gavrila, Ann Spicer, Jonathan Badrock, Francesca Bernuzzi, Vincenzo Cardinale,

˜The œLancet. Gastroenterology & hepatology · 2018 · 163 citations · 20 references

DOIFull text

Open access

Concepts

References

20

EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis

Gideon M. Hirschfield, Ulrich Beuers, Christophe Corpechot et al. · Journal of Hepatology · 2017 · 1.5K citations · Full text

, , +13

Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis)

J. Ludwig, E. Rolland Dickson, G. S. A. McDonald · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · 1978 · 762 citations

, , +9

A Multicenter, Controlled Trial of Ursodiol for the Treatment of Primary Biliary Cirrhosis

R.E. Poupon, Beverley Balkau, É. Eschwège et al. · New England Journal of Medicine · 1991 · 761 citations · Full text

, , +14

T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection

Eoin McKinney, James Lee, David Jayne et al. · Nature · 2015 · 691 citations · Full text

, , +14

A Placebo-Controlled Trial of Bezafibrate in Primary Biliary Cholangitis

Christophe Corpechot, Olivier Chazouillères, Alexandra Rousseau et al. · New England Journal of Medicine · 2018 · 611 citations · Full text

, , +17